Sources told Reuters that the deal is modeled on a similar agreement inked between FTC and Cigna’s pharmacy benefit manager ...

The Federal Trade Commission has agreed to what it called a “landmark” settlement with Express Scripts, allowing the company to bow out of the agency’s lawsuit against major pharmacy benefit managers ...

Express Scripts was the first to cap out-of-pocket costs for insulin medications at $25 for a 30-day supply in 2019, well before the government took action ST. LOUIS, Sept. 20, 2024 /PRNewswire/ -- ...

CVS Health's Caremark has become the second of the "Big Three" pharmacy benefit managers to reach a settlement with the Federal Trade Commission (FTC) in a lawsuit over insulin pricing. | CVS Health's ...

The potential deal comes about a year and a half after the FTC first brought the case against Express Scripts, CVS’ Caremark and UnitedHealth’s Optum Rx. If approved, the agreement would mark the ...

The Federal Trade Commission has announced what it called a "landmark settlement" with Express Scripts over insulin pricing. The settlement resolves a lawsuit alleging that Express Scripts' conduct ...

The Federal Trade Commission said it has reached a settlement with Express Scripts, resolving an earlier lawsuit that alleged the pharmacy benefit manager artificially inflated insulin drug prices.

The Federal Trade Commission and Cigna's Evernorth unit have officially reached a settlement that resolves allegations that the company's pharmacy benefit manager artificially drove up prices for ...

The FTC paused its administrative case against major pharmacy benefit managers, including Cigna's Express Scripts and Evernorth Health, staying proceedings and discovery deadlines until July 1 to ...

Federal regulators announced a settlement Wednesday with Express Scripts to change how the company handles prescription drug pricing. The agreement aims to lower out-of-pocket costs for patients who ...